PeptiDream Inc.
PeptiDream Inc. has 1 licensing announcement in this dataset, dated 2024-04-30.
- Country / operating region
- Japan
- Ticker
- 4587.T
- Headquarters
- 查無
- Founded
- 2006
- Business
- Biopharmaceutical research and development
- Website
- www.peptidream.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| PDPS macrocyclic peptide programs | 查無 | 查無 | 查無 | 2024-04-30 |
| Asset | Registered / announced phase | Trial | Status | Sponsor | Record date |
|---|---|---|---|---|---|
| PDPS macrocyclic peptide programs | 查無 | — | 查無 | 查無 | 2024-04-30 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2024-04-30 | Novartis Pharma AG | PDPS macrocyclic peptide programs | USD 180m | 查無 | ≤ USD 2710m | 查無 | Original agreement subject to antitrust conditions; company follow-up dated 2024-06-14 states clearance obtained. |
| Counterparty | Territory | Royalties |
|---|---|---|
| Novartis Pharma AG | 查無 | Tiered royalties on net sales. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無